Dr. Maurice Chagnaud, aged 62 years, is a Doctor of Medicine and has done his Masters of Business Administration (Marketing, Strategy, Finance and Administration) from IAE Aix- en-Provence, France. He has done the Strategic Finance Program from IMD, Lausanne, Switzerland.

He has over 27 years of senior executive position in Pharmaceutical business having worked with Pharma majors like Lipha, Merck Kga, Merck Generics, Teva, Lupin and Polpharma as General Manager, Chief Commercial Officer Europe, President and CEO. He had also served as director on the Board of Advanz Pharma, a global pharmaceutical company. He is known for his strong Leadership skills, strategic vision, sharp analytical skills, execution ability, managing complexity, result orientation, and ability to quickly access new situation.

He is the CEO & founder of Mac Healthcare Consulting AG, a boutique consultancy company providing advisory services and support to Financial Sector and Pharma Companies in different sector of activities (generics, OTC, specialities, Biosimilars etc.) wherein he specializes in working on commercial assessment, due-diligence, M&A and strategy development. He recently was involved in several acquisitions (Stada, Zentiva, Rimser, Serb, Theramex, Neurax etc) with different Private Equity entities (Bain, Charterhouse, Blackstone, Carlyle, PAI etc.)

He currently serves as the Director on the Board of Remedica Ltd, Cyprus and Farmak, Ukrainia.